REGISTRATION FOR THIS EVENT HAS CLOSED
The 4th annual Medicine by Design Symposium will bring together principal investigators and trainees from across the University of Toronto and its affiliated hospitals, along with members of our Scientific Advisory Board, to advance our successful research collaborations toward impact.
Sessions will include:
Novel regenerative medicine approaches to disease treatment
A panel discussion on enabling early-stage translation
- Moderator: Michael May, Chief Executive Officer, CCRM
- Panellists: Dr. Jane Batt, Respirologist and Scientist, Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, and Associate Professor, Faculty of Medicine, U of T; Dawn Bell, Chief Scientific Officer, Novartis Canada and Associate, Creative Destruction Lab; Cynthia Lavoie, Managing Director, AllosteRx Capital; and Phil Vanek, General Manager, Cell and Gene Therapy Strategy, GE Healthcare Life Sciences
Overcoming translational barriers
The symposium will also include an opportunity for trainees in Medicine by Design-funded labs to present their research during a poster session.
Registration and Poster Abstract Submission
We have reached capacity. Registration for this event has closed.
Trainee Poster Abstract Submission and Registration
The deadline to submit poster abstracts was Oct. 9, 2019. We are no longer accepting abstracts.